SCIENTIFIC BACKGROUND

CBL

Category:

The CBL gene (Cas-Br-M (murine) ecotropic retroviral transforming sequence) is a proto-oncogene whose protein, E3 ubiquitin-protein ligase CBL, functions as a negative regulator of several signal transduction pathways including the Ras/MAP kinase signal transduction pathway. Somatic variants and translocations of this gene are found in many cancer types, including acute myeloid leukemia. The CBL gene is located on chromosome 11q23.

 

Juvenile myelomonocytic leukemia (JMML) is a rare form of leukemia in infancy and early childhood which is characterized by malignant transformation in the hematopoietic stem cell compartment. JMML accounts for 30% of myelodysplastic syndrome cases and 2% of all leukemias. 10 to 15% of children affected by neurofibromatosis type 1 with associated pathogenic variants in the neurofibromin gene develop JMML. Patients with Noonan syndrome or Noonan syndrome-like disorder due to germline alterations in the PTPN11, KRAS, and NRAS genes also have a predisposition to JMML. Isolated forms of JMML may include somatic PTPN11 variants as well as homozygous CBL variants.

 

In a few patients presenting with symptoms of Noonan syndrome, in whom pathogenic variants in genes typical for Noonan syndrome have been excluded, germline variants in the CBL gene can be detected. Most of these occur de novo. These patients may have concurrent JMML. This has been shown to be caused by a subsequent somatic LOH (loss of heterozygosity) on chromosome 11q23, where the CBL gene is located.

 

References

Zenker et Kutsche 2016, medgen 28:15 / Bulow et al. 2015 Am J Med Genet 167A:394 / Martinelli et al. 2010, Am J Hum Genet 87:250 / Perez et al. 2010, J Med Genet 47:686 / Niemeyer et al. 2010, Nature Genet 42:794 / De Filippi et al. 2009, Brit J Haematol 147:706 / Schubbert et al. 2006, Nature Genet 38:331 / Jongmans et al. 2005, Am J Med Genet 134A:165

GENES

CBL

ASSOCIATED TESTS

How to order

LATEST ARTICLES

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of ...

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access...

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is...

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti...

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati...

Read more